C O N M E D Corp (CNMD) Stock Price, Quote & News

Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instrument...

Industry: Medical Devices

Sector: Healthcare

Phone: 727 392 6464

Website: www.conmed.com

Address:

11311 Concept Boulevard, Largo, United States

NVDAMillionaire May. 13 at 10:32 PM

$CNMD Really good write-up that perfectly summarizes CNMD's present situation. So if you want to bring your CNMD knowledge up to date or just discover CNMD, this is required reading. https://everyticker.com/quote/CNMD/analysis/conmed-s-surgical-transformation-three-platforms-one-focus-and-the-path-to-medtech-premium-valuation-nasdaq-cnmd

0 · Reply

BillionerOfKing May. 11 at 5:00 PM

$CNMD Current Stock Price: $35.07 Contracts to trade: $35.0 CNMD May 15 2026 Call Entry: $0.70 Exit: $1.20 ROI: 71% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

OfficialStocktwitsUser May. 2 at 2:31 AM

$CNMD RSI: 42.71, MACD: -0.2443 Vol: 1.55, MA20: 37.50, MA50: 38.66 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

SuperGreenToday May. 1 at 10:00 AM

$CNMD Share Price: $36.71 Contract Selected: Nov 20, 2026 $35 Calls Buy Zone: $4.45 – $5.50 Target Zone: $7.79 – $9.52 Potential Upside: 65% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

StocktwitsEarnings Apr. 29 at 8:40 PM

$CNMD Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.45 up 136.84% YoY • Reported revenue of $317.05M down -1.31% YoY • Conmed is raising its full-year 2026 organic constant currency revenue growth outlook to 5.0% to 6.5% and expects reported revenue of $1.350 billion to $1.375 billion. Conmed reaffirms full-year adjusted diluted net earnings per share in the range of $4.30 to $4.45.

0 · Reply

cubie Apr. 27 at 3:15 PM

$CMPX $CNMD $AGAE @judgeyoung2 cubie teaches thats why u read a person's post history to see how often they are Right Vs Wrong, when these tards are wrong almost 90-100% time. u do the opposite judge, cubie's teaches 🤭🫡

1 · Reply

JACK_TRADZ Apr. 20 at 1:41 PM

$ENVB read what i said early on! 👇💸🔥 $PBM $CNMD

0 · Reply

dred48 Apr. 6 at 6:51 PM

$CNMD 2013 lows …

0 · Reply

SuperGreenToday Mar. 23 at 11:57 PM

$CNMD

0 · Reply

anachartanalyst Mar. 17 at 11:01 AM

$CNMD https://anachart.com/wp-content/uploads/ana_temp/1773745269_soc-img.jpg

0 · Reply

Conmed price target lowered to $40 from $43 at JPMorgan

2026-04-29T21:34:59.000Z - 14 days ago

Conmed reports Q1 EPS 89c, consensus 82c

2026-04-29T21:33:47.000Z - 14 days ago

Conmed backs FY26 EPS view of $4.30-$4.45, consensus $4.45

Apr 29, 2026, 4:30 PM EDT - 14 days ago

CONMED Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:05 PM EDT - 14 days ago

CONMED Corporation Announces First Quarter 2026 Financial Results

Apr 2, 2026, 4:05 PM EDT - 5 weeks ago

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

2026-03-18T10:31:09.000Z - 2 months ago

Conmed assumed with an Equal Weight at Wells Fargo

2026-03-17T08:55:31.000Z - 2 months ago

Conmed downgraded to Neutral from Overweight at Piper Sandler

ISRG

Jan 28, 2026, 4:30 PM EST - 3 months ago

CONMED Earnings Call Transcript: Q4 2025

2026-01-28T21:11:39.000Z - 3 months ago

Conmed reports Q4 adjusted EPS $1.43, consensus $1.32

2026-01-28T21:11:02.000Z - 3 months ago

Conmed sees FY26 adjusted EPS $4.30-$4.45, consensus $4.42

Jan 28, 2026, 4:05 PM EST - 3 months ago

CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results

Jan 12, 2026, 6:00 PM EST - 4 months ago

CONMED Transcript: 44th Annual J.P. Morgan Healthcare Conference

2026-01-08T22:00:39.000Z - 4 months ago

Conmed CFO Todd Garner to step down, effective March 15

2026-01-08T22:00:30.000Z - 4 months ago

Conmed backs FY25 adjusted EPS, revenue guidance

Jan 8, 2026, 4:55 PM EST - 4 months ago

CONMED Corporation Announces Chief Financial Officer Transition

Jan 5, 2026, 4:10 PM EST - 4 months ago

CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:05 PM EST - 4 months ago

CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026

2025-12-10T21:25:30.000Z - 5 months ago

Conmed announces 1-for-40 reverse share split

2025-12-07T23:55:11.000Z - 5 months ago

Conmed price target lowered to $52 from $65 at BofA

2025-12-05T13:11:22.000Z - 5 months ago

Conmed to conclude distribution agreement with W. L. Gore & Associates

2025-12-05T13:10:47.000Z - 5 months ago

Conmed backs FY25 adjusted EPS view $4.48-$4.53, consensus $4.50

2025-12-05T13:05:19.000Z - 5 months ago

Conmed to exit gastroenterology product lines

Dec 5, 2025, 8:00 AM EST - 5 months ago

CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines

2025-11-06T13:43:53.000Z - 6 months ago

Conmed price target lowered to $52 from $58 at JPMorgan

2025-11-06T13:38:21.000Z - 6 months ago

Conmed price target lowered to $55 from $68 at Piper Sandler

Nov 5, 2025, 4:30 PM EST - 6 months ago

CONMED Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:05 PM EST - 6 months ago

CONMED Corporation Announces Third Quarter 2025 Financial Results

Oct 2, 2025, 4:05 PM EDT - 7 months ago

CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025

Sep 9, 2025, 4:05 PM EDT - 8 months ago

CONMED Corporation Adds Kim Kelderman to its Board of Directors

Aug 8, 2025, 7:00 AM EDT - 9 months ago

CONMED Corporation Announces Quarterly Cash Dividend

Jul 30, 2025, 4:30 PM EDT - 10 months ago

CONMED Earnings Call Transcript: Q2 2025

Jul 30, 2025, 4:05 PM EDT - 10 months ago

CONMED Corporation Announces Second Quarter 2025 Financial Results

Jul 7, 2025, 5:00 PM EDT - 11 months ago

Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.

Jul 2, 2025, 4:05 PM EDT - 11 months ago

CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025

May 21, 2025, 7:03 AM EDT - 1 year ago

CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors

Apr 30, 2025, 4:30 PM EDT - 1 year ago

CONMED Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:05 PM EDT - 1 year ago

CONMED Corporation Announces First Quarter 2025 Financial Results

Apr 2, 2025, 4:05 PM EDT - 1 year ago

CONMED Corporation to Announce First Quarter 2025 Financial Results on April 30, 2025

Feb 25, 2025, 7:03 AM EST - 1 year ago

CONMED Corporation Adds Mark Kaye to its Board of Directors

Feb 5, 2025, 4:30 PM EST - 1 year ago

CONMED Earnings Call Transcript: Q4 2024

Feb 5, 2025, 4:05 PM EST - 1 year ago

CONMED Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results

Jan 13, 2025, 7:30 PM EST - 1 year ago

CONMED Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 6, 2025, 4:16 PM EST - 1 year ago

CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025

Jan 2, 2025, 4:05 PM EST - 1 year ago

CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

Dec 3, 2024, 12:30 PM EST - 1 year ago

CONMED Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 6:00 AM EST - 1 year ago

CONMED Transcript: Jefferies London Healthcare Conference 2024

Nov 19, 2024, 8:35 AM EST - 1 year ago

CONMED Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 4:05 PM EST - 1 year ago

CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference

Nov 4, 2024, 4:05 PM EST - 1 year ago

CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 19-20

Oct 30, 2024, 4:30 PM EDT - 1 year ago

CONMED Earnings Call Transcript: Q3 2024

Oct 30, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation Announces Third Quarter 2024 Financial Results

Oct 30, 2024, 4:02 PM EDT - 1 year ago

CONMED Corporation Announces Leadership Succession

Oct 4, 2024, 8:00 AM EDT - 1 year ago

CONMED Corporation Announces Preliminary Third Quarter Financial Information

Sep 16, 2024, 10:15 AM EDT - 1 year ago

CONMED Transcript: CL King’s 22nd Annual Best Ideas Conference 2024

Sep 12, 2024, 11:21 AM EDT - 1 year ago

Carpal Tunnel Release Systems Market Forecast Report 2024-2030, Featuring Profiles of Arthrex, Conmed, Innomed, MicroAire Surgical Instruments, Resurgens Orthopaedics, S2S Surgical and Trice Medical

Sep 4, 2024, 8:00 AM EDT - 1 year ago

CONMED Transcript: 2024 Wells Fargo Healthcare Conference

Sep 3, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference

Aug 19, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference

Jul 31, 2024, 4:30 PM EDT - 1 year ago

CONMED Earnings Call Transcript: Q2 2024

Jul 31, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation Announces Second Quarter 2024 Financial Results

Jul 8, 2024, 4:30 PM EDT - 2 years ago

CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024

Jun 6, 2024, 8:00 AM EDT - 2 years ago

CONMED Transcript: Jefferies Global Healthcare Conference

May 23, 2024, 4:05 PM EDT - 2 years ago

CONMED Corporation to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

May 14, 2024, 5:20 PM EDT - 2 years ago

CONMED Transcript: BofA Securities 2024 Health Care Conference

May 1, 2024, 4:05 PM EDT - 2 years ago

CONMED Corporation to Present at the BofA Securities Healthcare Conference

Apr 24, 2024, 4:30 PM EDT - 2 years ago

CONMED Earnings Call Transcript: Q1 2024

Apr 24, 2024, 4:05 PM EDT - 2 years ago

CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer

Apr 24, 2024, 4:03 PM EDT - 2 years ago

CONMED Corporation Announces First Quarter 2024 Financial Results

Apr 2, 2024, 4:05 PM EDT - 2 years ago

CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024

Jan 31, 2024, 4:30 PM EST - 2 years ago

CONMED Earnings Call Transcript: Q4 2023

Jan 31, 2024, 4:05 PM EST - 2 years ago

CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Jan 8, 2024, 5:15 PM EST - 2 years ago

CONMED Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 3, 2024, 4:05 PM EST - 2 years ago

CONMED Corporation to Announce Fourth Quarter 2023 Financial Results on January 31, 2024

Nov 28, 2023, 9:00 AM EST - 2 years ago

CONMED Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 15, 2023, 6:30 AM EST - 2 years ago

CONMED Transcript: Jefferies London Healthcare Conference 2023

Oct 31, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15

Oct 25, 2023, 4:30 PM EDT - 2 years ago

CONMED Earnings Call Transcript: Q3 2023

Oct 25, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation Announces Third Quarter 2023 Financial Results

Oct 4, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation to Announce Third Quarter 2023 Financial Results on October 25, 2023

Sep 7, 2023, 2:15 PM EDT - 2 years ago

CONMED Transcript: Wells Fargo Securities Healthcare Conference 2023

Jul 26, 2023, 4:30 PM EDT - 3 years ago

CONMED Earnings Call Transcript: Q2 2023

Jul 26, 2023, 4:05 PM EDT - 3 years ago

CONMED Corporation Announces Second Quarter 2023 Financial Results

Jul 5, 2023, 4:05 PM EDT - 3 years ago

CONMED Corporation to Announce Second Quarter 2023 Financial Results on July 26, 2023

May 25, 2023, 4:05 PM EDT - 3 years ago

CONMED Corporation to Participate in a Fireside Chat at the Jefferies Healthcare Conference

Apr 26, 2023, 4:30 PM EDT - 3 years ago

CONMED Earnings Call Transcript: Q1 2023

Apr 26, 2023, 4:05 PM EDT - 3 years ago

CONMED Corporation Announces First Quarter 2023 Financial Results

Apr 4, 2023, 4:05 PM EDT - 3 years ago

CONMED Corporation to Announce First Quarter 2023 Financial Results on April 26, 2023

Mar 22, 2023, 4:05 PM EDT - 3 years ago

CONMED Corporation Announces Annual Meeting of Stockholders

Mar 14, 2023, 4:05 PM EDT - 3 years ago

CONMED Corporation to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences and MedTech Investor Forum

Feb 2, 2023, 4:30 PM EST - 3 years ago

CONMED Earnings Call Transcript: Q4 2022

Feb 2, 2023, 4:05 PM EST - 3 years ago

CONMED Corporation Announces Fourth Quarter and Full-Year 2022 Financial Results

Jan 9, 2023, 4:05 PM EST - 3 years ago

CONMED Corporation to Announce Fourth Quarter 2022 Financial Results on February 2, 2023

NVDAMillionaire May. 13 at 10:32 PM

0 · Reply

BillionerOfKing May. 11 at 5:00 PM

0 · Reply

OfficialStocktwitsUser May. 2 at 2:31 AM

0 · Reply

SuperGreenToday May. 1 at 10:00 AM

0 · Reply

StocktwitsEarnings Apr. 29 at 8:40 PM

0 · Reply

cubie Apr. 27 at 3:15 PM

1 · Reply

JACK_TRADZ Apr. 20 at 1:41 PM

$ENVB read what i said early on! 👇💸🔥 $PBM $CNMD

0 · Reply

dred48 Apr. 6 at 6:51 PM

$CNMD 2013 lows …

0 · Reply

SuperGreenToday Mar. 23 at 11:57 PM

$CNMD

0 · Reply

anachartanalyst Mar. 17 at 11:01 AM

$CNMD https://anachart.com/wp-content/uploads/ana_temp/1773745269_soc-img.jpg

0 · Reply

TheMarketsTheTarget Mar. 14 at 4:41 AM

$CNMD IV potentially $39.74 at 10%.

0 · Reply

ZacksResearch Mar. 10 at 2:57 PM

$CNMD has headwinds — but the growth drivers are still in play ⚖️ AirSeal, Buffalo Filter, and BioBrace remain key growth engines as supply chains normalize, though tariffs and a GI exit are putting pressure on EPS. See why the stock may still deserve a spot in your portfolio 👉 https://www.zacks.com/stock/news/2881663/heres-why-you-should-retain-conmed-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2881663-teaser-36727&ADID=SYND_STOCKTWITS_TWEET_2_2881663_TEASER_36727

0 · Reply

ZacksResearch Mar. 10 at 1:57 PM

$CNMD down 27.1% in six months — what's dragging it down? 📉 ⚠️ Tariff headwinds and higher operating expenses are impacting EPS. 🔄 Strategic exit from gastroenterology aims to boost margins long-term. 📊 Q1 2026 revenue and EPS estimates suggest declines from the year-ago period. Full analysis here 👉 https://www.zacks.com/stock/news/2881663/heres-why-you-should-retain-conmed-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2881663-body-36725&ADID=SYND_STOCKTWITS_TWEET_2_2881663_BODY_36725

0 · Reply

SuperGreenToday Feb. 21 at 12:30 PM

$CNMD Share Price: $45.15 Contract Selected: Aug 21, 2026 $45 Calls Buy Zone: $2.55 – $3.15 Target Zone: $4.55 – $5.56 Potential Upside: 69% ROI Time to Expiration: 180 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

d_risk Feb. 17 at 4:59 PM

$CNMD - CONMED Corporation - 10K - Updated Risk Factors CNMD’s 2026 10-K sharpens legal and regulatory landmines (global anti-bribery, healthcare, FDA and privacy regimes), adds detailed capital-structure and interest-rate risks (new secured debt, convertibles, leverage, preferreds, dividends halted), flags heavier geopolitical, reimbursement, cyber/AI, distribution, divestiture and international exposure, and underscores dependence on key partners and talent. #HealthcareIndustry #RegulatoryCompliance #FinancialRisk #GeopoliticalRisk #Cybersecurity 🟢 Added 🟠 Removed https://d-risk.ai/CNMD/10-K/2026-02-17

0 · Reply

ZacksResearch Feb. 10 at 6:24 PM

Why I’m holding $CNMD — patience could pay here 👀 CONMED’s growth story is anchored in AirSeal, Buffalo Filter, and BioBrace as supply chains normalize, even though tariffs and a GI exit are pressuring EPS in the near term. Is this a steady hold while the setup improves? Full view here 👉 https://www.zacks.com/stock/news/2848399/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2848399-teaser-32944&ADID=SYND_STOCKTWITS_TWEET_2_2848399_TEASER_32944

0 · Reply

ZacksResearch Feb. 10 at 5:24 PM

Is $CNMD poised for a comeback despite a 20.6% drop over the past six months? 📉 🔥 Strong growth drivers in high-margin segments like AirSeal and Buffalo Filter support its long-term prospects. ⚠️ Yet, tariff headwinds and strategic exits are expected to impact fiscal 2026 earnings, with EPS projected to dip from $4.59 to $4.30-$4.45. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2848399/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2848399-body-32921&ADID=SYND_STOCKTWITS_TWEET_2_2848399_BODY_32921

0 · Reply

BlueChipBroker Feb. 4 at 2:20 PM

$CNMD is a medical device company focused on orthopedic implants; it operates in a competitive market and faces pricing pressure from hospital customers.

0 · Reply

ZacksResearch Jan. 29 at 6:02 PM

$CNMD beats earnings but faces a tough road ahead! 🚧 Despite a strong Q4 with adjusted EPS of $1.43, beating estimates by 8.6% and a 7.9% revenue boost, its operating margin took a 536 bps hit. Plus, a Zacks Rank #5 (Strong Sell) spells caution. Understand the risks before investing in CNMD 👉 https://www.zacks.com/stock/news/2825569/conmed-stock-up-post-q4-earnings-and-revenue-beat-gross-margin-up?cid=sm-stocktwits-2-2825569-body-31034&ADID=SYND_STOCKTWITS_TWEET_2_2825569_BODY_31034

0 · Reply

ZacksResearch Jan. 29 at 5:02 PM

CNMD pops after earnings — surgeons delivered, margins followed. 🚀 $CNMD posted strong fourth-quarter 2025 results with an EPS and revenue beat, driven by surgical growth and improved gross margin — exactly what the market wants to see. See why this quarter mattered 👉 https://www.zacks.com/stock/news/2825569/conmed-stock-up-post-q4-earnings-and-revenue-beat-gross-margin-up?cid=sm-stocktwits-2-2825569-teaser-31015&ADID=SYND_STOCKTWITS_TWEET_2_2825569_TEASER_31015

0 · Reply

StocktwitsEarnings Jan. 28 at 9:20 PM

$CNMD Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.54 down -50.46% YoY • Reported revenue of $373.2M up 7.88% YoY • Conmed Corp. expects full-year 2026 reported revenue between $1.345 billion and $1.375 billion, with adjusted diluted net earnings per share projected in the range of $4.30 to $4.45, including a $0.10 currency tailwind.

0 · Reply

Market Cap	1.06B
Revenue (ttm)	1.37B
Net Income (ttm)	47.06M
EPS (ttm)	N/A
PE Ratio	8.08
Forward PE	8.40
Profit Margin	3.42%
Debt to Equity Ratio	0.85

Volume	328,138
Avg Vol	431,388
Day's Range	N/A - N/A
Shares Out	30.11M
Stochastic %K	24%
Beta	0.94
Analysts	Hold
Price Target	$42.00